Effect of arginine on angiogenesis induced by human colon cancer: In vitro and in vivo studies

Chiu Li Yeh, Man Hui Pai, Cheng Chung Li, Yu Ling Tsai, Sung Ling Yeh

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

This study investigated the effect of arginine (Arg) supplementation on angiogenesis in human colon cancer. The in vitro study investigated the effects of different Arg levels and inducible nitric oxide (iNO) synthase inhibitor on angiogenic protein expressions stimulated by SW480 cells. The results showed that the production of vascular endothelial growth factor (VEGF), basic fibroblast growth factor with 100 and 1000 μmol/L Arg and matrix metalloproteinase (MMP)-2 with 1000 μmol/L Arg was lower than that with 0 and 50 μmol/L Arg. Inhibition of iNO resulted in higher angiogenic protein expressions comparable with groups with low Arg administration, indicating that Arg administration at levels similar to or higher than physiological concentrations reduced the progression of colon cancer, and iNO may partly play a role in reducing angiogenesis. The in vivo study used a human colon cancer xenograft model in nude mice. Mice were inoculated with 1×107 SW480 cells and assigned to two groups. The control group was fed a semipurified diet, while the experimental group was supplied an Arg-supplemented diet. After 5 weeks, tumors were harvested and spleens were excised for further analysis. Results showed that the MMP-2, MMP-9 and VEGF receptor levels in tumors were significantly lower, whereas tumor NO levels and spleen natural killer (NK) cell activities were higher in the Arg group than in the control group. These results were consistent with the in vitro study that dietary Arg supplementation inhibits the progression of colon cancer possibly by increasing NO secretion and consequently enhancing NK cell activity.

Original languageEnglish
Pages (from-to)538-543
Number of pages6
JournalJournal of Nutritional Biochemistry
Volume21
Issue number6
DOIs
Publication statusPublished - Jun 2010

Fingerprint

Colonic Neoplasms
Arginine
Angiogenic Proteins
Tumors
Matrix Metalloproteinase 2
Nutrition
Natural Killer Cells
Nitric Oxide
Spleen
In Vitro Techniques
Diet
Neoplasms
Control Groups
Vascular Endothelial Growth Factor Receptor
Matrix Metalloproteinase 9
Nitric Oxide Synthase Type II
Fibroblast Growth Factor 2
Dietary Supplements
Heterografts
Nude Mice

Keywords

  • Angiogenic protein
  • Arginine
  • Inducible nitric oxide
  • Natural killer cell
  • Nude mice
  • SW480

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Molecular Biology
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics
  • Medicine(all)

Cite this

Effect of arginine on angiogenesis induced by human colon cancer : In vitro and in vivo studies. / Yeh, Chiu Li; Pai, Man Hui; Li, Cheng Chung; Tsai, Yu Ling; Yeh, Sung Ling.

In: Journal of Nutritional Biochemistry, Vol. 21, No. 6, 06.2010, p. 538-543.

Research output: Contribution to journalArticle

@article{c0a7eccd4d5e430cbfbecd3a9f956296,
title = "Effect of arginine on angiogenesis induced by human colon cancer: In vitro and in vivo studies",
abstract = "This study investigated the effect of arginine (Arg) supplementation on angiogenesis in human colon cancer. The in vitro study investigated the effects of different Arg levels and inducible nitric oxide (iNO) synthase inhibitor on angiogenic protein expressions stimulated by SW480 cells. The results showed that the production of vascular endothelial growth factor (VEGF), basic fibroblast growth factor with 100 and 1000 μmol/L Arg and matrix metalloproteinase (MMP)-2 with 1000 μmol/L Arg was lower than that with 0 and 50 μmol/L Arg. Inhibition of iNO resulted in higher angiogenic protein expressions comparable with groups with low Arg administration, indicating that Arg administration at levels similar to or higher than physiological concentrations reduced the progression of colon cancer, and iNO may partly play a role in reducing angiogenesis. The in vivo study used a human colon cancer xenograft model in nude mice. Mice were inoculated with 1×107 SW480 cells and assigned to two groups. The control group was fed a semipurified diet, while the experimental group was supplied an Arg-supplemented diet. After 5 weeks, tumors were harvested and spleens were excised for further analysis. Results showed that the MMP-2, MMP-9 and VEGF receptor levels in tumors were significantly lower, whereas tumor NO levels and spleen natural killer (NK) cell activities were higher in the Arg group than in the control group. These results were consistent with the in vitro study that dietary Arg supplementation inhibits the progression of colon cancer possibly by increasing NO secretion and consequently enhancing NK cell activity.",
keywords = "Angiogenic protein, Arginine, Inducible nitric oxide, Natural killer cell, Nude mice, SW480",
author = "Yeh, {Chiu Li} and Pai, {Man Hui} and Li, {Cheng Chung} and Tsai, {Yu Ling} and Yeh, {Sung Ling}",
year = "2010",
month = "6",
doi = "10.1016/j.jnutbio.2009.03.005",
language = "English",
volume = "21",
pages = "538--543",
journal = "Journal of Nutritional Biochemistry",
issn = "0955-2863",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Effect of arginine on angiogenesis induced by human colon cancer

T2 - In vitro and in vivo studies

AU - Yeh, Chiu Li

AU - Pai, Man Hui

AU - Li, Cheng Chung

AU - Tsai, Yu Ling

AU - Yeh, Sung Ling

PY - 2010/6

Y1 - 2010/6

N2 - This study investigated the effect of arginine (Arg) supplementation on angiogenesis in human colon cancer. The in vitro study investigated the effects of different Arg levels and inducible nitric oxide (iNO) synthase inhibitor on angiogenic protein expressions stimulated by SW480 cells. The results showed that the production of vascular endothelial growth factor (VEGF), basic fibroblast growth factor with 100 and 1000 μmol/L Arg and matrix metalloproteinase (MMP)-2 with 1000 μmol/L Arg was lower than that with 0 and 50 μmol/L Arg. Inhibition of iNO resulted in higher angiogenic protein expressions comparable with groups with low Arg administration, indicating that Arg administration at levels similar to or higher than physiological concentrations reduced the progression of colon cancer, and iNO may partly play a role in reducing angiogenesis. The in vivo study used a human colon cancer xenograft model in nude mice. Mice were inoculated with 1×107 SW480 cells and assigned to two groups. The control group was fed a semipurified diet, while the experimental group was supplied an Arg-supplemented diet. After 5 weeks, tumors were harvested and spleens were excised for further analysis. Results showed that the MMP-2, MMP-9 and VEGF receptor levels in tumors were significantly lower, whereas tumor NO levels and spleen natural killer (NK) cell activities were higher in the Arg group than in the control group. These results were consistent with the in vitro study that dietary Arg supplementation inhibits the progression of colon cancer possibly by increasing NO secretion and consequently enhancing NK cell activity.

AB - This study investigated the effect of arginine (Arg) supplementation on angiogenesis in human colon cancer. The in vitro study investigated the effects of different Arg levels and inducible nitric oxide (iNO) synthase inhibitor on angiogenic protein expressions stimulated by SW480 cells. The results showed that the production of vascular endothelial growth factor (VEGF), basic fibroblast growth factor with 100 and 1000 μmol/L Arg and matrix metalloproteinase (MMP)-2 with 1000 μmol/L Arg was lower than that with 0 and 50 μmol/L Arg. Inhibition of iNO resulted in higher angiogenic protein expressions comparable with groups with low Arg administration, indicating that Arg administration at levels similar to or higher than physiological concentrations reduced the progression of colon cancer, and iNO may partly play a role in reducing angiogenesis. The in vivo study used a human colon cancer xenograft model in nude mice. Mice were inoculated with 1×107 SW480 cells and assigned to two groups. The control group was fed a semipurified diet, while the experimental group was supplied an Arg-supplemented diet. After 5 weeks, tumors were harvested and spleens were excised for further analysis. Results showed that the MMP-2, MMP-9 and VEGF receptor levels in tumors were significantly lower, whereas tumor NO levels and spleen natural killer (NK) cell activities were higher in the Arg group than in the control group. These results were consistent with the in vitro study that dietary Arg supplementation inhibits the progression of colon cancer possibly by increasing NO secretion and consequently enhancing NK cell activity.

KW - Angiogenic protein

KW - Arginine

KW - Inducible nitric oxide

KW - Natural killer cell

KW - Nude mice

KW - SW480

UR - http://www.scopus.com/inward/record.url?scp=77952883869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952883869&partnerID=8YFLogxK

U2 - 10.1016/j.jnutbio.2009.03.005

DO - 10.1016/j.jnutbio.2009.03.005

M3 - Article

C2 - 19447018

AN - SCOPUS:77952883869

VL - 21

SP - 538

EP - 543

JO - Journal of Nutritional Biochemistry

JF - Journal of Nutritional Biochemistry

SN - 0955-2863

IS - 6

ER -